• 0
MENU
Cart Details

Nidcal CL Tablet

Product Informations: Nidcal CL Tablet

In Osteoporosis Osteoporosis is a common condition that causes bones to become fragile and brittle so that they break (fracture) more easily. Fractures may be painful and restrict a person’s ability to carry out their normal daily tasks. Nidcal CL Tablet reduces the risk of a fracture occurring in osteoporosis. It also helps in the growth and development of bones as well as maintain strong bones. Along with medicines, eat a balanced diet rich in calcium and vitamin D like dairy products, green leafy vegetables etc.

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Nidcal CL Tablet is to be taken empty stomach.
Nidcal CL Tablet is a combination medicine used in the treatment of osteoporosis. It prevents bone loss and makes the bones stronger. This way it helps in preventing bone fractures. Nidcal CL Tablet is best taken in an empty stomach. You should take it regularly at a fixed time each day. Taking it at the same time every day will help you remember to take it. It may take several days to get the full benefit of this drug. Do not stop taking the medicine until your doctor tells you it is alright to stop. This medicine may only be part of a treatment program that may also include changes to your diet and taking other medicines and vitamin supplements. The most common side effects of this medicine include headache, back pain, musculoskeletal (bone, muscle or joint) pain, indigestion, heartburn, and diarrhea. These are generally mild and usually resolve on their own. If they do not go away or get worse, you should let your doctor know. Your doctor may be able to suggest ways of preventing or reducing the side effects. Before using this medicine, let your doctor know if you have any medical conditions or disorders. To make sure the medicine is safe for you, let your doctor also know all the other medicines you are taking. You may need frequent medical tests to check your kidney function and mineral levels while on treatment with this medicine. You should avoid consuming large amounts of alcohol, as it can cause bone loss. Pregnant and breastfeeding mothers should consult their doctors before using this medicine.
  • Increased calcium level in blood
  • Abdominal pain
  • Nausea
  • Rash
  • Urinary tract infection
Alcohol : UNSAFE

It is unsafe to consume alcohol with Nidcal CL Tablet.

Pregnancy : CONSULT YOUR DOCTOR

Nidcal CL Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding : SAFE IF PRESCRIBED

Nidcal CL Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.

Driving : SAFE

Nidcal CL Tablet does not usually affect your ability to drive.

Kidney : CAUTION

Nidcal CL Tablet should be used with caution in patients with kidney disease. Dose adjustment of Nidcal CL Tablet may be needed. Please consult your doctor. No dose adjustment is recommended in patients with mild to moderate kidney disease. However, use of Nidcal CL Tablet is not advised in severe kidney disease patients.

Liver : SAFE IF PRESCRIBED

Nidcal CL Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Nidcal CL Tablet may not be needed in these patients. Please consult your doctor.

If you miss a dose of Nidcal CL Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Habit Forming::No|Therapeutic Class::PAIN ANALGESICS

FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra


Alternatives and Substitutes


Customer Reviews

No customer reviews yet.

References

FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More

European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More

ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More

Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More



Available options.

Same salt composition: Calcitriol (0.25mcg) + Calcium Carbonate (500mg) + Zinc (7.5mg) + Risedronate (35mg)

Test Buy medical disposable face mask
to protect your loved ones